CNR Institutional Research Information System

CAMPOLO, JONICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.234
NA - Nord America 1.398
EU - Europa 584
SA - Sud America 484
AF - Africa 43
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.750
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.322
SG - Singapore 979
CN - Cina 448
BR - Brasile 404
VN - Vietnam 270
HK - Hong Kong 226
IT - Italia 157
FR - Francia 124
NL - Olanda 102
KR - Corea 69
BD - Bangladesh 51
JP - Giappone 49
FI - Finlandia 43
IN - India 41
DE - Germania 36
GB - Regno Unito 34
CA - Canada 32
AR - Argentina 30
MX - Messico 25
ID - Indonesia 18
ZA - Sudafrica 18
SE - Svezia 14
EC - Ecuador 12
TR - Turchia 11
AT - Austria 10
PL - Polonia 10
CL - Cile 9
CO - Colombia 9
IL - Israele 9
IQ - Iraq 9
ES - Italia 8
IE - Irlanda 7
SA - Arabia Saudita 7
AE - Emirati Arabi Uniti 6
PY - Paraguay 6
UA - Ucraina 6
UZ - Uzbekistan 6
AZ - Azerbaigian 5
CZ - Repubblica Ceca 5
JM - Giamaica 5
PE - Perù 5
TN - Tunisia 5
DO - Repubblica Dominicana 4
MA - Marocco 4
MY - Malesia 4
PK - Pakistan 4
RU - Federazione Russa 4
VE - Venezuela 4
AL - Albania 3
BO - Bolivia 3
CH - Svizzera 3
EG - Egitto 3
ET - Etiopia 3
KE - Kenya 3
LT - Lituania 3
LV - Lettonia 3
NG - Nigeria 3
PH - Filippine 3
AU - Australia 2
CR - Costa Rica 2
GP - Guadalupe 2
HR - Croazia 2
IR - Iran 2
JO - Giordania 2
KZ - Kazakistan 2
LB - Libano 2
MT - Malta 2
NO - Norvegia 2
OM - Oman 2
PS - Palestinian Territory 2
RO - Romania 2
SN - Senegal 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AM - Armenia 1
BG - Bulgaria 1
BS - Bahamas 1
CV - Capo Verde 1
DZ - Algeria 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
KG - Kirghizistan 1
KH - Cambogia 1
LC - Santa Lucia 1
LK - Sri Lanka 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PF - Polinesia Francese 1
PG - Papua Nuova Guinea 1
PT - Portogallo 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
WS - Samoa 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.750
Salva come PNG Salva come JPEG
Città #
Singapore 583
Santa Clara 466
Hong Kong 219
Hefei 151
San Jose 143
Beijing 125
Lauterbourg 101
Ashburn 92
Los Angeles 84
Ho Chi Minh City 81
Dallas 79
Seoul 69
Hanoi 55
Tokyo 39
New York 37
São Paulo 34
Helsinki 28
Milan 23
Buffalo 21
Cascina 17
Orem 17
Naples 16
Council Bluffs 13
Da Nang 13
Frankfurt am Main 13
Stockholm 13
Toronto 13
Johannesburg 12
Lappeenranta 12
Rio de Janeiro 12
Belo Horizonte 11
Lucca 10
Mexico City 10
Brasília 9
Haiphong 9
Rome 9
Atlanta 8
Hải Dương 8
London 8
Manchester 8
Brooklyn 7
Campinas 7
Chicago 7
Curitiba 7
Denver 7
Dhaka 7
Falkenstein 7
Minamishinagawa 7
Montreal 7
Phoenix 7
Poplar 7
Amsterdam 6
Bengaluru 6
Biên Hòa 6
Florence 6
Guangzhou 6
Houston 6
Mumbai 6
New Delhi 6
Nuremberg 6
Tashkent 6
Vienna 6
Warsaw 6
Ankara 5
Baku 5
Can Tho 5
Chennai 5
Dublin 5
Düsseldorf 5
Fortaleza 5
Guarulhos 5
Monza 5
Prague 5
Quito 5
Santiago 5
Santo André 5
Turin 5
Agrate Brianza 4
Baghdad 4
Bogotá 4
Boston 4
Bắc Giang 4
Cape Town 4
Columbus 4
Guayaquil 4
Ha Long 4
Juiz de Fora 4
Maringá 4
Padova 4
Porto Alegre 4
Salvador 4
Shanghai 4
Thái Bình 4
Addis Ababa 3
Aracaju 3
Barranquilla 3
Bắc Ninh 3
Casablanca 3
Caxias do Sul 3
Elk Grove Village 3
Totale 2.975
Salva come PNG Salva come JPEG
Nome #
SMARTool: Interim Progress Report (M19-M30) 127
Correlates of olfactory impairment in middle-aged non-diabetic Caucasian subjects with stage I-II obesity 125
SMARTool - Periodic Technical Report - PART B (Period 2) 108
Cancer Risk in Patients With Congenital Heart Disease Exposed to Radiation From Cardiac Procedures 82
Lysyl oxidase expression and collagen cross-linking during chronic adriamycin nephropathy 76
Telomere Length, Mitochondrial DNA, and Micronucleus Yield in Response to Oxidative Stress in Peripheral Blood Mononuclear Cells 72
Blood Monocyte Phenotype Fingerprint of Stable Coronary Artery Disease: A Cross-Sectional Substudy of SMARTool Clinical Trial 72
METABOLIC AND CARDIAC AUTONOMIC CORRELATES OF THE CUORE SCORE IN NON DIABETICS WITH STAGE I-II OBESITY IN LATE MIDDLE-AGE 70
Influence of Chromosome 9p21.3 rs1333049 Variant on Telomere Length and Their Interactive Impact on the Prognosis of Coronary Artery Disease 69
Biochemical but not imaging parameters are predictive of outcome in septic shock: a pilot study 68
ARTREAT Human Data Collection and Model Modifications (D4.4.1) 66
Triglycerides and low HDL cholesterol predict coronary heart disease risk in patients with stable angina 66
Computing of low shear stress-driven endothelial gene network involved in early stages of atherosclerotic process 65
The burden of radiation exposure in congenital heart disease: the Italian cohort profile and bioresource collection in HARMONIC project 64
Gender-Specific Behaviour in Obesity Stages I-II: Imbalance of Aminothiol Status and Adipomyokine Profile in Subjects with Different Insulin Resistance Severity 63
Coronary blood flow, metabolism and function in dysfunctional viable myocardium before and early after surgical revascularization 62
A serving of blueberry (V. corymbosum) acutely improves peripheral arterial dysfunction in young smokers and non-smokers: two randomized, controlled, crossover pilot studies 60
Irisin and markers of metabolic derangement in non-diabetic Caucasian subjects with stage I-II obesity during early aging 59
Blood gluthatione as a marker of cardiac allograft vasculopathy in heart transplant recipients 58
Clinical and Biological Predictors of Cancer Incidence and Mortality in Patients with Stable Coronary Artery Disease 58
Vascular senescence and atherosclerotic plaque vulnerability: investigating the telomere-mitochondria crosstalk—rationale and design of the VICTORIA Study 58
The mitochondrial dysfunction, alongside the modifiable burden of traditional risk factors, drives the development of early-onset coronary artery disease 56
Low leptin plasma levels are associated with progression of coronary atherosclerosis in patients with stable coronary artery disease from the SMARTool Study 55
Myocardial interleukin-6 in the setting of left ventricular mechanical assistance: relation with outcome and C-reactive protein. 55
Time course of the modified endstage liver disease score and oxidative stress early after left ventricular assist device implant for end stage heart failure 53
Innate Immunity and Coronary Atherosclerosis Progression: putative cellular and molecular marker. 53
SMARTool: Periodic Technical Report - Part B 53
Early Expression of Pro- and Anti-Inflammatory Cytokines in Left Ventricular Assist Device Recipients With Multiple Organ Failure Syndrome 51
Nutrigenetic Interactions Might Modulate the Antioxidant and Anti-Inflammatory Status in Mastiha-Supplemented Patients With NAFLD 50
Upregulation of chemokine receptor CXCR4 and caspase-dependent apoptosis genes can synergistically favour activation of endothelial cells exposed to low shear stress 50
DOREMI - Target users and scenarios of use (D2.1) 48
Plasma Amino Acids in NAFLD Patients with Obesity Are Associated with Steatosis and Fibrosis: Results from the MAST4HEALTH Study 48
Vascular injury post stent implantation: Different gene expression modulation in Human Umbilical Vein Endothelial Cells (HUVECs) model 47
Medium-term effect of sublingual L-glutathione supplementation on flow-mediated dilation in subjects with cardiovascular risk factors 47
Time-course of plasma NT-pro C-type natriuretic peptide in end-stage heart failure patients supported by left ventricular assist device implant. 46
Relationship between Early Inflammatory Response and Clinical Evolution of the Severe Multiorgan Failure in Mechanical Circulatory Support-Treated Patients 45
Analytical performance and method comparison study of the total homocysteine fluorescence polarization immunoassay (FPIA) on the AxSYM analyzer. 44
A Longitudinal Study of Individual Radiation Responses in Pediatric Patients Treated with Proton and Photon Radiotherapy, and Interventional Cardiology: Rationale and Research Protocol of the HARMONIC Project 44
Long Telomeric Repeat-Containing RNA (TERRA): Biological Functions and Challenges in Vascular Aging and Disease 43
Effect of Mastiha supplementation on NAFLD: The MAST4HEALTH Randomised, Controlled Trial 43
High-performance liquid chromatographic determination of total plasma homocysteine with or without internal standards 43
A single blueberry (Vaccinium corymbosum) portion does not affect markers of antioxidant defence and oxidative stress in healthy volunteers following cigarette smoking 43
Biological and Proteomic characterization of a composite mesh for abdominal wall hernia treatment: Reference Study 43
GENETIC MARKERS IN CARDIAC RESYNCHRONIZATION THERAPY TREATMENT SUCCESS 42
Intra- and interday repeatability of peripheral arterial function: suitability and potential limitations 41
Effects of combined dietary supplementation on oxidative and inflammatory status in dyslipidemic subjects 41
Evaluation of thiol redox status in hyperlipidemic patients on lipid-lowering and antioxidant treatment 41
Hyperlipidemia and Oxidative Stress: Evaluation Of PUFA n-3 Vitamin E and gamma-Oryzanol Combination. 40
Lo stress ossidativo e l'attivazione dell'infiammazione nello scompenso cardiaco terminale non migliorano durante la prima fase (1 mese) dopo impianto di assistenza ventricolare meccanica sinistra (LVAD) 40
Blood glutathione as independent marker of lipid peroxidation in heart failure 40
Urinary neopterin, a new marker of the neuroinflammatory status in amyotrophic lateral sclerosis 39
Early intra-aortic balloon pump in acute decompensated heart failure complicated by cardiogenic shock: Rationale and design of the randomized Altshock-2 trial 38
DOREMI - Active Ageing Lifestyle Protocol (D2.2) 38
Health effects of ionising radiation in paediatrics undergoing either cardiac fluoroscopy or modern radiotherapy (The HARMONIC project) 38
Critical study of preanalytical and analytical phase of adenine and pyridine nucleotide assay in human whole blood. 38
Super-normal Tl-201 retention in hibernating myocardium: an ex-vivo study using the failing human heart 36
Time-course of plasma NT-proc-type natriuretic peptide in end-stage heart failure patients supported by left ventricular assist device implant. 36
Neopterin levels are independently associated with cardiac remodeling in patients with chronic heart failure 36
BIOLOGICAL AND INSTRUMENTAL MARKERS OF ENDOTHELIAL DYSFUNCTION IN CADASIL (CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY) 36
Effects of Sapropterin on Endothelium-Dependent Vasodilation in Patients With CADASIL A Randomized Controlled Trial 35
Cardiogenic Shock Integrated PHenotyping for Event Reduction: A Pilot Metabolomics Analysis 35
Plasma glutathione levels are independently associated with ?-glutamyltransferase activity in subjects with cardiovascular risk factors 34
Oxidative stress and thiol redox state in patients with coronary and carotid artery atherosclerosis 34
Relaxin and endothelin-1 axis in heart failure patients: First evidence of their transcriptional profiling in during left ventric- ular assist device support 33
Pre-operative interleukin-6 levels and pronounced postoperative inflammatory response are associated to INTERMACS profile before left ventricular assist device implantation 33
Congenital Heart Disease and the Risk of Cancer: An Update on the Genetic Etiology, Radiation Exposure Damage, and Future Research Strategies 32
Oxidative stress and inflammatory activation in end-stage heart failure do not ameliorate during early phase (1 month) of left ventricular mechanical assistance 32
ARTREAT Human Data Collection and Coronary Model Modifications (D4.4.2) 32
Aminothiol redox alterations in patients with chronic heart failure of ischaemic or non-ischaemic origin 32
Time-course of plasma NT-proc-type natriuretic peptide in end-stage heart failure patients supported by left ventricular assist device implant 32
A single portion of blueberry (Vaccinium corymbosum L) improves protection against DNA damage but not vascular function in healthy male volunteers 32
Paraoxonase 1 L55M, Q192R and paraoxonase 2 S311C alleles in atherothrombosis 31
Severity of oxidative stress and inflammatory activation in end-stage heart failure patients are unaltered after 1 month of left ventricular mechanical assistance 31
Impaired vasoreactivity in mildly disabled CADASIL patients 31
Repeatability of arterial function by EndoPAT2000: a potential tool for studying vasoreactivity of bioactive-rich foods 31
Reduced myocardial MMP-2, MMP-9 and gluatione peroxidase activities and elevated cytokine levesl in patients supported by left ventricular assist device 30
Low plasma glutathione levels after reperfused acute myocardial infarction are associated with late cardiac events 30
Methionine challenge paradoxically induces a greater activation of the antioxidant defence in subjects with hyper- vs normohomocysteinemia 30
Genetic variants associated to reverse remodelling after cardiac resynchronization therapy 29
Identification of genetic markers for treatment success in heart failure patients insight from cardiac resynchronization therapy 29
The role of PON2 311 Cys allele and risk factors in atherothrombotic event 29
Pre-operative interleukin-6 levels and pronounced postoperative inflammatory response are associated to INTERMACS profile before left ventricular assist 29
Is the Oxidant/Antioxidant Status Altered in CADASIL Patients? 29
Antioxidant and inflammatory biomarkers for the identification of prodromal Parkinson's disease 29
Automated APTT cycle for the rapid identification of plasma prekallikrein deficiency 29
Glutamate-cysteine ligase polymorphism, hypertension, and male sex are associated with cardiovascular events. Biochemical and genetic characterization of Italian subpopulation 28
Does left ventricular assist device implantation modulate the cardiac cell apoptosis in end-stage heart failure? 28
Analytical performance and method comparison study of the total homocysteine fluorescence polarization immunoassay (FPIA) on the AxSYM analyzer 27
Plasma cysteine and glutathione are independent markers of postmethionine load endothelial dysfunction 27
Association of liver inflammation and fibrosis score with non-invasive biomarkers in non-alcoholic fatty liver disease: Preliminary results from the MAST4HEALTH study 27
Myocardial redox state alterations and elevated cytokines levels in patients with end stage heart failure (ESHF) supported by left ventricular assist device (LVAD) 26
Genetic variants of the renin-angiotensin-aldosterone system and reverse remodeling after cardiac resynchronization therapy 26
In vitro effect of stent positioning on gene expression profile 26
Plasma cysteine and glutathione are independent markers of postmethionine load endothelial dysfunction 25
Genetic variants associated to reverse remodelling after cardiac resynchronization therapy 25
Coronary blood flow, metabolism and function in dysfunctional viable miocardium before and early after surgical revascularization 25
Reduction of cardiac metalloproteinase activity is sustained by amelioration of GSH bioavailability during left ventricular assist device support in failing heart. 25
Relationship Between Myocardial Redox State and Matrix Metalloproteinase Activity in Patients on Left Ventricular Assist Device Support 25
Cardiovascular risck burden, gamma-glutamyltransferase and redox state: an emerging link 25
Effect of a single blueberry portion on oxidative stress and endothelial function: a pilot study 24
Totale 4.430
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.260
article - articoli 12.262
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.522
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202414 0 0 0 0 0 0 0 1 1 0 12 0
2024/20251.917 3 6 130 63 399 145 84 96 56 129 445 361
2025/20262.925 129 291 319 526 578 109 374 132 123 181 163 0
Totale 4.856